IRIS Institutional Research Information System - OPENBS Open Archive UniBS

VITA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.572
EU - Europa 6.379
AS - Asia 4.455
Continente sconosciuto - Info sul continente non disponibili 35
OC - Oceania 32
SA - Sud America 24
AF - Africa 10
Totale 27.507
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.514
CN - Cina 2.190
UA - Ucraina 1.976
IT - Italia 1.614
SG - Singapore 1.049
DE - Germania 797
HK - Hong Kong 574
TR - Turchia 389
FI - Finlandia 384
IE - Irlanda 379
GB - Regno Unito 370
PL - Polonia 312
FR - Francia 176
IN - India 116
SE - Svezia 107
CZ - Repubblica Ceca 98
CA - Canada 53
BE - Belgio 50
ID - Indonesia 37
AU - Australia 31
EU - Europa 29
IR - Iran 28
VN - Vietnam 23
NL - Olanda 22
RU - Federazione Russa 16
AT - Austria 11
CH - Svizzera 11
SA - Arabia Saudita 11
ES - Italia 10
BR - Brasile 8
HU - Ungheria 8
GR - Grecia 7
PH - Filippine 7
JP - Giappone 6
RO - Romania 6
A1 - Anonimo 5
PE - Perù 5
LT - Lituania 4
MU - Mauritius 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BD - Bangladesh 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
CO - Colombia 3
EC - Ecuador 3
SI - Slovenia 3
AM - Armenia 2
EE - Estonia 2
HN - Honduras 2
KG - Kirghizistan 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MX - Messico 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CL - Cile 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MS - Montserrat 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
ZA - Sudafrica 1
Totale 27.507
Salva come PNG Salva come JPEG
Città #
Fairfield 2.179
Woodbridge 1.782
Jacksonville 1.536
Houston 1.299
Ashburn 1.130
Chandler 1.119
Singapore 878
Cambridge 856
Seattle 838
Ann Arbor 807
Wilmington 781
Princeton 720
Hong Kong 567
Nanjing 507
New York 406
Dublin 375
Istanbul 355
Brescia 329
Warsaw 312
Beijing 250
Helsinki 246
Nanchang 182
Milan 168
Des Moines 160
Dearborn 154
Changsha 144
Shenyang 133
Hebei 124
Lancaster 124
Jinan 122
Tianjin 118
Boardman 117
San Diego 106
Munich 105
Jiaxing 80
Shanghai 76
Rome 75
Brno 70
Hangzhou 62
Romola 60
Zhengzhou 53
London 51
Kunming 50
San Mateo 49
Washington 41
Los Angeles 39
Brussels 37
Toronto 37
Ningbo 33
Norwalk 33
Jakarta 32
Lanzhou 31
Augusta 30
Haikou 30
Orange 30
San Francisco 30
Guangzhou 29
Leawood 28
Taizhou 26
Olomouc 25
Verona 25
Dong Ket 22
Kocaeli 21
Monmouth Junction 18
Taiyuan 18
Fuzhou 17
Lappeenranta 16
Redwood City 16
Turin 16
Ardabil 15
Bologna 14
Changchun 14
Coventry 11
Gent 11
Kilburn 11
Palermo 11
Melbourne 10
Mumbai 10
Santa Clara 10
Tehran 10
Cagliari 9
Frankfurt am Main 9
Hounslow 9
Mantova 9
Sydney 9
Canberra 8
Cologno Monzese 8
Pavia 8
Prescot 8
Riyadh 8
Rozzano 8
Florence 7
Genoa 7
Manchester 7
Pescara 7
Poncarale 7
Bari 6
Bolzano 6
Hefei 6
Moscow 6
Totale 20.614
Salva come PNG Salva come JPEG
Nome #
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 445
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 265
Il training cognitivo nei pazienti affetti da schizofrenia 187
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 180
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies 171
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 169
Cognitive remediation in schizophrenia: current status and future perspectives. 162
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): a nationwide snapshot of the status of treatment for major depression. 160
Correlates of autistic traits among patients with borderline personality disorder 154
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 149
Combined measure of smooth pursuit eye movements and ventricle-brain ratio in schizophrenic disorders. 145
Autism spectrum disorder and schizophrenia: Do they overlap? 144
Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia? 142
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 141
Psychiatric hospitalization rates in italy before and during covid-19: Did they change? an analysis of register data 141
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 137
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. 135
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 134
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 133
Adult Autism Subthreshold Spectrum (AdAS Spectrum): Validation of a questionnaire investigating subthreshold autism spectrum 133
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 132
Cognitive remediation in schizophrenia. 130
Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. 129
Effects of cognitive remediation therapy on neurocognition and negative symptoms in schizophrenia: an Italian naturalistic study 128
Autistic traits in a sample of adult patients with schizophrenia: prevalence and correlates 128
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 128
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 127
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 126
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. 126
Factors Associated With Brain Heterogeneity in Schizophrenia 125
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 124
A roadmap to disentangle the molecular etiology of schizophrenia 122
Adherence to antipsychotics in schizophrenia. 121
X-linked mental retardation with Marfanoid habitus. First report of four italian patients. 121
A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. 120
Cognitive remediation in the early course of schizophrenia: a critical review. 118
Tools for measuring clinical effectiveness. 117
HLA-DR antigens in schizophrenia. 117
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study. 116
Virological and immunological study of schizophrenic patients in relation to CT scan abnormality. 114
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 113
Age of onset in familial schizophrenia. 112
Season of birth and cerebral ventricular enlargement in schizophrenia 112
Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice 112
Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis 112
Brain morphology in schizophrenic disorder: prevalence and correlates of diffuse (cortical and subcortical) brain atrophy. 111
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 111
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies 111
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 111
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 111
A reconsideration of the relationship between cerebral structural abnormalities and family history of schizophrenia. 110
Non pharmacological strategies to enhance adherence and continuity of care in schizophrenia. 110
Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. 109
A genome-wide search for schizophrenia susceptibility genes. 108
Cognitive remediation in schizophrenia: background, techniques, evidence of efficacy and perspectives 108
Autistic symptoms predict social cognitive performance in patients with schizophrenia 108
Early life events and affective disorder revisited. 107
Lack of evidence for linkage to chromosomes 13 and 8 for schizophrenia and schizoaffective disorder 107
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 106
Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome 105
Persistence of effectiveness of cognitive remediation interventions in schizophrenia: A 1-year follow-up study. 105
Patterns of Structural MRI Abnormalities in Deficit and Nondeficit Schizophrenia. 104
Longitudinal studies of brain morphology and outcome of schizophrenic disorder 104
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 104
Cortical atrophy in schizophrenia: prevalence and associated features 103
Cognitive remediation in schizophrenia: a controlled study 103
The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. 103
Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. 102
Il rimedio cognitivo nelle psicosi: principi e metodi. 102
Structural brain abnormalities in bipolar disorder: what meta-analyses tell us 101
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study. 101
Il training cognitivo della Terapia Psicologica Integrata (IPT): presupposti e descrizione. 101
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies 101
Failure to find a chromosome 18 pericentric linkage in families with schizophrenia 100
Neuromorphological correlates of mood disorders: focus on cerebral ventricular enlargement. 100
Language and thought disorder in schizophrenia: brain morphological correlates. 99
Hippocampal and amygdala volume reductions in first-episode schizophrenia. 99
Qualitative MRI findings in patients with schizophrenia: a controlled study. 99
Uso della PET e della SPECT in psichiatria 99
Cerebral ventricular abnormalities in schizophrenia: evidence of their early origin and stability over time. 99
Magnetic resonance imaging findings in schizophrenia: relationships with language and thought disorders, symptomatology and cognitive performance. 99
CT scan abnormalities and outcome of chronic schizophrenia 98
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. 98
Brain structural effects of antidepressant treatment in major depression 98
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 98
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 98
Psychosocial Rehabilitation in Italy Today 97
Outcome of positive and negative symptoms during neuroleptic therapy in schizophrenia 97
Male siblings with schizophrenia share alleles at the androgen receptor above chance expectation. 97
Cerebral ventricular enlargement as a generalized feature of schizophrenia: a distribution analysis on 502 subjects. 96
CLINICAL ASSESSMENT OF COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA THROUGH THE SCHIZOPHRENIA COGNITION RATING SCALE: A VALIDATION STUDY IN THE ITALIAN POPULATION 96
La cognitività sociale nella schizofrenia: modelli interpretativi e strategie di intervento 96
Non-selective impairment of Wisconsin Card Sorting Test performance in patients with schizophrenia. 95
Poor adherence to antipsychotic medication in people with schizophrenia: diffusion, consequences and contributing factors. 95
Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice 95
COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. 94
No evidence for a parent-of-origin effect detected in the pattern of inheritance of schizophrenia. 94
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. 94
Clinical-biological patterns and prediction of response to haloperidol in schizophrenia 94
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 94
Totale 12.042
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.299 0 0 0 0 0 758 679 733 455 841 421 412
2020/20214.794 111 581 191 497 185 580 143 534 541 572 604 255
2021/20222.574 185 463 58 150 39 124 123 200 136 284 188 624
2022/20233.141 411 30 31 329 246 798 28 366 550 54 153 145
2023/20243.083 207 90 249 209 167 558 109 84 634 81 58 637
2024/20252.067 93 98 144 820 866 46 0 0 0 0 0 0
Totale 28.273